News Image

Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024

Provided By GlobeNewswire

Last update: Oct 4, 2024

Houston, Texas and Tuebingen, Germany, October 4, 2024 Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced upcoming oral and poster presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer in Houston, Texas from November 6 - 10, 2024.

Read more at globenewswire.com

IMMATICS NV

NASDAQ:IMTX (7/24/2025, 8:00:02 PM)

After market: 6.45 0 (0%)

6.45

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more